%0 Journal Article
%T 新生儿溶血病的治疗进展<br>Progress in the Treatment of Hemolytic Disease of the Newborn
%A 王桃
%A 姜泓
%J Advances in Clinical Medicine
%P 18632-18639
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.13122619
%X 新生儿溶血病(HDN)是由于母体与新生儿血型不合，母体产生抗体，并通过胎盘输入胎儿体内，造成胎儿红细胞破坏而发生的溶血，严重威胁新生儿的生命健康。降低血中胆红素水平，预防胆红素脑病是治疗的关键。治疗包括产前治疗和新生儿期治疗。新生儿治疗主要包括光照疗法、药物治疗以及换血疗法等。本文基于新生儿溶血病的治疗进展进行讨论，为临床诊治新生儿溶血病提供一定的理论依据。<br />
Hemolytic disease of the newborn (HDN) is a hemolysis caused by the incompatibility of blood types between the mother and the newborn, where the mother produces antibodies and inputs them into the fetus through the placenta, causing damage to fetal red blood cells and posing a serious threat to the life and health of the newborn. Reducing the level of bilirubin in the blood and preventing bilirubin encephalopathy are the key to treatment. Treatment includes prenatal and neonatal treatment. Neonatal treatment mainly includes phototherapy, drug therapy, and blood exchange therapy. This article discusses the treatment progress of neonatal hemolytic disease, providing a theoretical basis for clinical diagnosis and treatment of neonatal hemolytic disease.
%K 新生儿溶血病，治疗，综述<br>Neonatal Hemolytic Disease
%K Treatment
%K Summary
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=76514